Article
Replicon RNA vaccines: design, delivery, and immunogenicity in infectious diseases and cancer
16 Apr 2025
Abstract excerpt
Replicon RNA (RepRNA) represents a cutting-edge technology in the field of vaccinology, fundamentally transforming vaccine design and development. This innovative approach facilitates the induction of robust immune responses against a range of infectious diseases and cancers. RepRNA vaccines leverage the inherent capabilities of RNA-dependent RNA polymerase associated with self-replicating repRNA, allowing for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
